"A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice (Real-World), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers"

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

November 6, 2023

Study Completion Date

November 6, 2023

Conditions

Hemophilia A

Interventions

OTHER

No intervention

Retrospective analysis using database without any intervention assigned in the study.

Trial Locations (3)

Regents of the University of Minnesota, Minneapolis

Tulane University, New Orleans

University of California, Davis, Sacramento